Cantitate/Preț
Produs

Molecular Genetics of Endometrial Carcinoma: Advances in Experimental Medicine and Biology, cartea 943

Editat de Lora Hedrick Ellenson
en Limba Engleză Hardback – 16 dec 2016
This comprehensive text provides a much-needed review of a disease that is currently garnering the interest of molecular biologists, translational scientists, and clinicians. The volume includes emerging developments in the molecular genetics of endometrial carcinoma. In addition to covering the basic genetics of endometrial carcinoma, chapters also cover a wide range of signaling pathways implicated in endometrial carcinoma. A section of the book includes a number of genetically engineered mouse models, which contribute to understanding the role of various genetic alterations in the development and progression of endometrial carcinoma.  These models also provide preclinical models for developing effective targeted therapeutic approaches. Endometrial carcinoma is the most common malignancy of the female genital tract in the United States and the number of cases continues to increase around the world. This book is a meant to serve as a resource for a wide range of scientists,from molecular geneticists to signal transduction biologists, as well as to both clinicians and scientists interested in developing targeted therapeutic approaches for women with endometrial carcinoma.

Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 107206 lei  6-8 săpt.
  Springer International Publishing – 4 iul 2018 107206 lei  6-8 săpt.
Hardback (1) 107890 lei  6-8 săpt.
  Springer International Publishing – 16 dec 2016 107890 lei  6-8 săpt.

Din seria Advances in Experimental Medicine and Biology

Preț: 107890 lei

Preț vechi: 113568 lei
-5% Nou

Puncte Express: 1618

Preț estimativ în valută:
20650 21664$ 17130£

Carte tipărită la comandă

Livrare economică 29 ianuarie-12 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319431376
ISBN-10: 3319431374
Pagini: 328
Ilustrații: XI, 281 p. 32 illus., 31 illus. in color.
Dimensiuni: 155 x 235 x 18 mm
Greutate: 0.59 kg
Ediția:1st ed. 2017
Editura: Springer International Publishing
Colecția Springer
Seria Advances in Experimental Medicine and Biology

Locul publicării:Cham, Switzerland

Cuprins

Part 1. Introduction.- 1. Epidemiology and metabolic/hormonal influences.- 2. Pathology.- 3. Clinical behavior and treatment.- Part 2. Molecular Profiling.- 4. Traditional approaches.- 5. Next generation sequencing.- 6. Specific Pathways.- Part 3. Mouse models.- 7. Pten.- 8. Mig-6.- 9. Lkb.- Part 4. 10. Future Directions.- Index.

Notă biografică

Dr. Lora Hedrick Ellenson is Professor of Pathology and Laboratory Medicine and Director of the Division of Gynecological Pathology at Weill Cornell Medicine. She has a national reputation for her expertise in endometrial carcinoma. Dr. Ellenson’s research interest is primarily focused on the molecular genetics and pathology of endometrial carcinoma, the most common malignancy of the female genital tract. In addition to satisfying her clinical duties, Dr. Ellenson oversees an NIH funded research program to develop genetic mouse models of endometrial tumorigenesis in addition to defining the differences, and similarities, in the molecular genetic alterations in the two major types of endometrial carcinoma. She has over 80 publications on the topic with over 3,430 citations.


Textul de pe ultima copertă

This comprehensive text provides a much-needed review of a disease that is currently garnering the interest of molecular biologists, translational scientists, and clinicians. The volume includes emerging developments in the molecular genetics of endometrial carcinoma. In addition to covering the basic genetics of endometrial carcinoma, chapters also cover a wide range of signaling pathways implicated in endometrial carcinoma. A section of the book includes a number of genetically engineered mouse models, which contribute to understanding the role of various genetic alterations in the development and progression of endometrial carcinoma.  These models also provide preclinical models for developing effective targeted therapeutic approaches. Endometrial carcinoma is the most common malignancy of the female genital tract in the United States and the number of cases continues to increase around the world. This book is meant to serve as a resource for a wide range of scientists, from molecular geneticists to signal transduction biologists, as well as to both clinicians and scientists interested in developing targeted therapeutic approaches for women with endometrial carcinoma.

Caracteristici

Explains the metabolic and hormonal influences of endometrial carcinoma Gives perspectives on traditional approaches and next-generation sequencing in the molecular profiling of endometrial carcinoma Reviews several signaling pathways and mouse models used to study cancer proliferation